Hancock Whitney Corp Mei Pharma, Inc. Transaction History

Hancock Whitney Corp

  • $3.07 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 04, 2021
SELL
$2.52 - $2.99 $126,332 - $149,894
-50,132 Closed
0 $0
Q2 2021

Aug 09, 2021
BUY
$2.6 - $3.65 $49,176 - $69,036
18,914 Added 60.59%
50,132 $143,000
Q2 2020

Jul 30, 2020
BUY
$1.45 - $4.3 $45,266 - $134,237
31,218 New
31,218 $129,000

Others Institutions Holding MEIP

# of Institutions
1
Shares Held
2K
Call Options Held
0
Put Options Held
0
View Full List

About MEI Pharma, Inc.

MEIP Quotes by TradingView
  • Ticker MEIP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 133,261,000
  • Market Cap $362M
  • Description
  • MEI Pharma, Inc., a late-stage pharmaceutical company, focuses on the development and commercialization of various therapies for the treatment of cancer. The company develops Zandelisib, an oral phosphatidylinositol 3-kinase delta inhibitor that is in Phase III clinical trial for the treatment of patients with relapsed/refractory follicular lymp...
More about MEIP
Track This Portfolio

Track Hancock Whitney Corp Portfolio

Follow Hancock Whitney Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hancock Whitney Corp, based on Form 13F filings with the SEC.

News

Stay updated on Hancock Whitney Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email